Guiding Aging Long-Term Opioid Therapy Users Into Safer Use Patterns
Study Details
Study Description
Brief Summary
Patients on long-term opioid therapy are aging and now face magnified risk of harm with continued high-dose opioid use. These increased risks are due to age-related changes in drug metabolism, multi-morbidity, and polypharmacy. The dominant approach to mitigate these risks is to screen for aberrant patient opioid behaviors so that clinicians can pre-empt misuse early through review of contractual opioid agreements or by lowering patient dosages. By focusing on opioid misuse alone, this strategy encourages forced opioid tapering that is associated with opioid overdose and mental health crisis. Directing clinician attention to the comorbid conditions associated with opioid misuse may promote safer and more effective care.
The objective of this study is to assess the comparative effectiveness of PainTracker, a set of questions that targets a broad range of problems associated with pain, in a randomized controlled trial involving 300 Northwestern Medicine clinicians treating Chronic Opioid Use Registry patients (n=5159).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Using the electronic health record, patient portal, and patient-reported outcome capabilities, the investigators will develop programming logic for a randomized experimentation platform wherein two or more versions of pain surveys may be delivered to patients. This system will be used to evaluate PainTracker, delivered to half of the sample (approximately 2,579 patients). Clinicians treating Chronic Opioid Use Registry patients that meet the inclusion criteria will be assigned to one of two conditions involving patient surveys: 1) Current Opioid Misuse Measure [COMM] [standard clinical care] or 2) COMM + PainTracker. Surveys will be delivered monthly and patients will be prompted 3 times to complete the survey; once completed, patients will receive a score also delivered to their physician's inbox in Epic.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No Intervention: Current Opioid Misuse Measure (COMM) On a monthly basis, patients will receive the abbreviated Current Opioid Misuse Measure (COMM), a 6-item self-report screener to identify and monitor the risk of aberrant opioid-related behavior in chronic pain patients on opioid therapy. The COMM asks patients to report their behaviors over the past 30 days using a five-point Likert-type rating scale. |
|
| Experimental: Current Opioid Misuse Measure (COMM) + PainTracker On a monthly basis, patients will receive both the abbreviated Current Opioid Misuse Measure (COMM) and PainTracker. PainTracker tracks multiple outcomes relevant to the treatment of chronic pain: pain severity, general activity interference, enjoyment of life interference, sleep (initiating and maintaining), depression, and anxiety. |
Behavioral: PainTracker
The PainTracker tool reframes the patient visit around improving functional status and obtaining functional goals, understanding psychological concerns that may exacerbate pain such as traumatic stress, anxiety, and depression. This approach may promote an increase in referrals for physical therapy, mental health counseling, and psychiatric follow-up.
|
Outcome Measures
Primary Outcome Measures
- Referral rate to non-opioid care [9 months]
Patient referral rate to non-opioid care that includes mental and behavioral health care, physical therapy, or sleep medicine referrals
- Antidepressant orders [9 months]
Rate of orders for antidepressant medications
Secondary Outcome Measures
- Clinician monthly milligram morphine equivalent (MME) [9 months]
Clinician aggregate monthly milligram (mg) morphine equivalent (ME) for >50 mg ME daily dose visits
- Benzodiazepine prescribing [9 months]
Clinician aggregate monthly milligram (mg) valium equivalent (VE) for >50 mg VE daily dose visits
Eligibility Criteria
Criteria
Inclusion Criteria:
• Patients age 65 or older on long-term opioid therapy within the Northwestern Medicine Chronic Opioid Use registry system with at least one primary care encounter in the past 12 months.
Exclusion criteria:
• Patient visits with active cancer diagnoses
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Southern California
- Northwestern University
- National Institute on Aging (NIA)
- University of Washington
Investigators
- Principal Investigator: Jason Doctor, PhD, University of Southern California
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HS-22-00517
- 3P30AG024968-20S1